If you cannot view this message properly, please click here
 Truffle Insiders
  n°11 - July 2009

Jean-François Fourt, Dr Philippe Pouletty,
Henri Moulard
and Bernard-Louis Roques

EDITORIAL

Venture Capital fund raising, boosted by the tax incentivized ‘retail funds’ scheme in France, remained consistant during H1 in France, amounting to €630 million for 2009 (versus €658 million in 2008) with €136,20 million going to FCPI investment funds. Truffle Capital, with the support of Union Financière de France has become France’s largest fundraiser last semester with €40 million raised in Q2. We wish to thank our investors for their renewed confidence.
 
Truffle Capital's strategy is continuing to bear fruit; according to the Chausson Finance index for H2 2008, Truffle Capital was ranked number 2 for total early-stage investments. We shall maintain our policy of financing innovative, high-potential start-ups and spin-outs in the energy, life science and IT sectors.

Knowing to anticipate and adapt itself to the conjuncture, Truffle Capital intends to optimize and intensify its offer toward investors (despite the fact that the ISF relief scheme is being rejigged), and to continue investing in innovation and hi-tech because we have the infrastructure and expertise for making the right investment choices, performing proactive follow-up and building tomorrow's technology leaders.

Henri Moulard
Jean-François Fourt
Dr Philippe Pouletty
Bernard-Louis Roques

Under the spotlight
Pharnext concludes a major agreement with IPSEN
In June, IPSEN (Euronext: IPN), an innovation-driven global pharmaceutical Group and Pharnext, a biopharmaceutical company specializing in the development of innovative treatments, announced they have entered into an exclusive research, development and marketing agreement regarding innovative drug candidates intended for the treatment of Charcot Marie-Tooth disease, a neuromuscular disorder that primarily impacts peripheral nerves...
 
Portfolio news
Information Technologies: NetBooster, RTL Belgium
Life Sciences: Carmat, Vexim, Symetis
Energy: Watteco, Dietswell
 
 

Truffle Capital - 5, rue de la Baume 75008 Paris - Tel: +33 1 47 20 22 20

www.truffle.com

 
 
OVERVIEW TEAM PHILOSOPHY INVESTMENTS FUNDS CONTACTS